Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology CongressBusiness Wire • Thursday
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/04/24
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/29/24
Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate UpdateBusiness Wire • 08/12/24
Astria Therapeutics Chooses Ypsomed's YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary AngioedemaBusiness Wire • 08/12/24
Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare ConferenceBusiness Wire • 08/07/24
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology CongressBusiness Wire • 05/23/24
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateBusiness Wire • 05/09/24
Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual MeetingBusiness Wire • 05/08/24
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAEBusiness Wire • 03/25/24
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate UpdateBusiness Wire • 03/04/24
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual MeetingBusiness Wire • 02/20/24
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences ConferenceBusiness Wire • 02/06/24
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy CongressBusiness Wire • 11/27/23
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx ConferenceBusiness Wire • 11/21/23
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate UpdateBusiness Wire • 11/13/23
Is a Surprise Coming for Astria Therapeutics (ATXS) This Earnings Season?Zacks Investment Research • 11/10/23
Astria Therapeutics Presents New Phase 1a Data Confirming Potential for STAR-0125 to Prevent Hereditary Angioedema Attacks with Dosing 2 or 4 Times Per Year at the 2023 American College of Allergy, Asthma, and Immunology Annual Scientific MeetingBusiness Wire • 11/10/23